The hearing screen instruments had a major share in the instruments segment with a market share of 28%. The growth in prenatal and newborn genetic testing market is majorly driven by awareness of various genetic and chromosomal disorders which can be screened with the help of advanced instruments and further course of action can be planned accordingly. The development of various healthcare technologies such as next generation sequencing, high throughput screening has helped to detect various abnormalities at an early stage. These tests are expected to grow at CAGR of 10.8% during the forecast period i.e. 2020-2025.
What is Prenatal testing and Newborn screening?
Prenatal diagnosis is a series of tests conducted during pregnancy to determine the health of the fetus at an early stage. These tests can determine various genetic and chromosomal anomalies such as birth defects, gene mutations, cystic fibrosis and so on. The purpose of prenatal diagnosis is the early detection of abnormal diseases so that a suitable treatment can be advised.
Newborn screening is the test carried out during the early days of the babies for detection of certain disorders which would hinder their growth and development. Various abnormalities such as phenylketonuria (PKU), galactosemia, sickle cell disease, congenital hypothyroidism are detected during these tests.
The report incorporates in-depth analysis of prenatal testing and newborn screening market by type, diagnostic techniques, technology, instruments and geography.
What are the major applications of Prenatal testing and Newborn screening?
Prenatal testing and newborn screening tests help to determine various genetic and chromosomal diseases. Genetic diseases such as sickle cell, down’s syndrome, cystic fibrosis and muscular dystrophy are detected with the help of these tests. It helps to provide timely medical or surgical treatment of a condition before or after birth. These tests also provide a chance to abort the fetus in case it has been diagnosed with a deadly disorder. It helps parents to prepare psychologically, socially, financially, and medically for a baby with a health problem. In some cases, extremely rare diseases can also be detected.
Market Research and Market Trends of Prenatal testing and Newborn screening:
In 2016, Eurofins LifeCodexx launched the first noninvasive prenatal test (NIPT) assay based on a quantitative real-time PCR for prenatal testing of fetal trisomy 21. This test is cost effective and has faster processing time when compared to the conventional PCR technique. Hence, it is widely used in molecular diagnostics as the test results are of highest quality standards. In 2020, Eurofins Genoma enhanced the NIPT technology that screens for both de novo – gene mutations, that are not inherited – and inherited single-gene disorders through simple blood tests.
Approximately 60 to 65 percent of the prenatal genetic tests are now switching to next-generation sequencing (NGS) methodologies. Emergence of NGS along with various microarray techniques provides a wider scope to create tests with better specificity and sensitivity. GeneVu, a product of Roche Holding AG uses next-generation sequencing to detect mutations and carriers during prenatal testing.
Whole-Exome Sequencing (WES) is analysis of all exons of all protein coding genes in the human genome. WES is a less costly and more efficient method in detecting mutations. However, WGS is useful as it analyzes around 3 billion base pairs and is more powerful than WES. At present, WGS is much more expensive than WES because of its sequencing technology and requires a large database to store, manage and analyze the data. WGS has been improving at a very fast rate and with the reduction in cost, it would be highly preferred over WES in clinical practice.
Qiagen, which solely focused on oncology has shifted its focus in the development of fetal cell-free DNA assays for prenatal testing technology. Pregnant mothers can undergo non-invasive prenatal testing to prevent birth defects in babies. This technology differentiates the fetal placental DNA from the background of the mother’s DNAs, further giving detail insight to the doctors pertaining to baby’s genetic issues.
Who are the Major Players in Prenatal testing and Newborn screening market?
The companies referred to in this market research report include Abbott laboratories, Thermo fisher Scientific, Qaigen, Bio-Rad, Strand life sciences, Roche Holding AG, Eurofins scientific, Natera Inc., Premaitha Health plc, Illumina, Inc., Quest diagnostics Inc.
What is our report scope?
The report incorporates in-depth assessment the competitive landscape, product market sizing, product benchmarking, market trends, product developments, financial analysis, strategic analysis so on to gauge the impact forces potential opportunities the market. Apart from this the report also includes a study major developments in the market such as product launches, agreements, acquisitions, collaborations, mergers so on to comprehend the prevailing market dynamics at present its impact during the forecast period 2020-2025.
Key Takeaways from this Report
- Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) Value ($M) data given at country level – for product types, end use applications by different industry verticals.
- Understand the different dynamics influencing the market – key driving factors, challenges hidden opportunities.
- Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT more.
- Analyze the sales distribution channels across key geographies to improve top-line revenues.
- Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value bring efficiencies in your processes.
- Get a quick outlook on the market entropy – M&A’s, deals, partnership and product launches all key players for the past 4 years.
- Evaluate the supply-dem gaps, import-export statistics regulatory lscape for more than top 20 countries globally for the market
This report will be delivered within 2 business days.
1.1. Definitions and Scope
2. Prenatal Testing & Newborn Screening Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Prenatal Testing & Newborn Screening Market
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis
4. Prenatal Testing & Newborn Screening Market Forces
4.4. Porters five force model
4.4.1. Bargaining power of suppliers
4.4.2. Bargaining powers of customers
4.4.3. Threat of new entrants
4.4.4. Rivalry among existing players
4.4.5. Threat of substitutes
5. Prenatal Testing & Newborn Screening Market -Strategic analysis
5.1. Value chain analysis
5.2. Opportunities analysis
5.3. Product life cycle
5.4. Suppliers and distributors Market Share
6. Prenatal Testing & Newborn Screening Market – by Types (Market Size -$Million / $Billion)
6.1. Market Size and Market Share Analysis
6.2. Application Revenue and Trend Research
6.3. Product Segment Analysis
6.3.2. Screening Tests
6.3.3. Diagnosis Tests
7. Prenatal Testing & Newborn Screening Market – by Diagnosing Technique (Market Size -$Million / $Billion)
7.2. Non Invasive
7.2.2. Pre-implementation Genetic Diagnosis
7.2.3. Fetal Cells in Maternal Circulation
7.2.4. Fetus-Free Fetal DNA
7.3.3. Fetal blood sampling
7.3.4. Embryoscopy & Fetoscopy
8. Prenatal Testing & Newborn Screening Market – by Screening Options (Market Size -$Million / $Billion)
8.2. First Trimester
8.2.1. Nuclear Translucency (NT)
8.2.2. Serum Screening
8.3. Second Trimester
8.3.1. Triple Screen
8.3.2. Quadruple Screen
8.3.3. Genetic Sonograms
8.3.4. Extended Sonogram
8.4. Third Trimester
8.4.1. Group B streptococcus screening
8.4.2. Electronic fetal heart monitoring
8.4.3. Contraction stress test
8.4.4. Non-stress test
8.5. Sequential Screening
9. Prenatal Testing & Newborn Screening Market – by Technology (Market Size -$Million / $Billion)
9.1. Tandem Mass Spectrometry
9.3. Enzymes and Immuno Assays
9.4. DNA Based Assays
9.5. Pulse Oximetry Technology
9.6. Hearing Screen Technology
10. Prenatal Testing & Newborn Screening Market – by Instruments (Market Size -$Million / $Billion)
10.1. Hearing screen instruments
10.2. Reagent Assay Kits
10.4. Tandem Quadrupole Detector
10.5. Incubator Shaker
11. Prenatal Testing & Newborn Screening - By Geography (Market Size -$Million / $Billion)
11.1. Prenatal Testing & Newborn Screening Market - North America Segment Research
11.2. North America Market Research (Million / $Billion)
11.2.1. Segment type Size and Market Size Analysis
11.2.2. Revenue and Trends
11.2.3. Application Revenue and Trends by type of Application
11.2.4. Company Revenue and Product Analysis
11.2.5. North America Product type and Application Market Size
188.8.131.52. Rest of North America
11.3. Prenatal Testing & Newborn Screening - South America Segment Research
11.4. South America Market Research (Market Size -$Million / $Billion)
11.4.1. Segment type Size and Market Size Analysis
11.4.2. Revenue and Trends
11.4.3. Application Revenue and Trends by type of Application
11.4.4. Company Revenue and Product Analysis
11.4.5. South America Product type and Application Market Size
184.108.40.206. Costa Rica
220.127.116.11. Rest of South America
11.5. Prenatal Testing & Newborn Screening - Europe Segment Research
11.6. Europe Market Research (Market Size -$Million / $Billion)
11.6.1. Segment type Size and Market Size Analysis
11.6.2. Revenue and Trends
11.6.3. Application Revenue and Trends by type of Application
11.6.4. Company Revenue and Product Analysis
11.6.5. Europe Segment Product type and Application Market Size
18.104.22.168. Rest of Europe
11.7. Prenatal Testing & Newborn Screening – APAC Segment Research
11.8. APAC Market Research (Market Size -$Million / $Billion)
11.8.1. Segment type Size and Market Size Analysis
11.8.2. Revenue and Trends
11.8.3. Application Revenue and Trends by type of Application
11.8.4. Company Revenue and Product Analysis
11.8.5. APAC Segment – Product type and Application Market Size
22.214.171.124. South Korea
12. Prenatal Testing & Newborn Screening Market - Entropy
12.1. New product launches
12.2. M&A's, collaborations, JVs and partnerships
13. Prenatal Testing & Newborn Screening Market Company Analysis
13.1. Market Share, Company Revenue, Products, M&A, Developments
13.2. 23 and Me
13.4. Agilent technologies
13.5. Babycentr llc
13.7. Color Genomics
13.9. Edinberg Genomics
13.10. Editas Medicine
13.11. Eurofins scientific
14. Prenatal Testing & Newborn Screening Market -Appendix